跳至主要内容
临床试验/CTRI/2023/03/050174
CTRI/2023/03/050174已完成3 期

A Clinical study on the efficacy of Krishnadi churna in Tamaka Shwasa W.S.R to Bronchial Asthma

Dr Amber1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年6月3日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Improvement in symptoms of Tamaka Shwasa

研究概览

简要总结

Tamaka Shwasa is one of the challenging diseases which afflict the human race. It is vata-kaphaja disease originating from pittasthana and manifested through pranavaha srotasa. It can be correlated to Bronchial Asthma which is a chronic inflammatory disease of airways associated with hyperresponsiveness of the tracheobronchial tree with cardinal symptoms like wheezing, chest tightness, breathlessness and cough. After taking into consideration the seriousness of the disease , present study has been designed to evaluate the effect of Krishnadi churna in the management of Tamaka Shwasa with special reference to Bronchial Asthma

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients presenting with signs and symptoms of Tamaka Shwasa for one or more years.
  • 2.Patients with 3 or more of the following symptoms like a.ghurghurakam b.nishtuyante kshanam sukham c.Shwasa krichta d.urah parshav peeda e.aseeno labhte saukhyam.
  • 3.Mild intermittent and persistent and moderate persistent asthma according to GINA classification.

排除标准

  • Severe persistent asthma according to GINA guidelines TB, COPD, emphysema, infectious and complicated respiratory disease, DM2.

结局指标

主要结局

Improvement in symptoms of Tamaka Shwasa

时间窗: 45 days

次要结局

  • Improvement in general health conditions(45 days)

研究者

发起方
Dr Amber
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验